Allosteric Antagonism of the Pregnane X Receptor (PXR): Current-State-of-the-Art and Prediction of Novel Allosteric Sites
The pregnane X receptor (PXR, <i>NR1I2</i>) is a xenobiotic-activated transcription factor with high levels of expression in the liver. It not only plays a key role in drug metabolism and elimination, but also promotes tumor growth, drug resistance, and metabolic diseases. It has been pr...
Main Authors: | Rajamanikkam Kamaraj, Martin Drastik, Jana Maixnerova, Petr Pavek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/19/2974 |
Similar Items
-
Target Hopping from Protein Kinases to PXR: Identification of Small-Molecule Protein Kinase Inhibitors as Selective Modulators of Pregnane X Receptor from TüKIC Library
by: Enni-Kaisa Mustonen, et al.
Published: (2022-04-01) -
The role of pregnane X receptor (PXR) in substance metabolism
by: Ye Lv, et al.
Published: (2022-08-01) -
In Silico Prediction and Validation of CB2 Allosteric Binding Sites to Aid the Design of Allosteric Modulators
by: Jiayi Yuan, et al.
Published: (2022-01-01) -
Structural analysis of protein tyrosine phosphatase 1B reveals potentially druggable allosteric binding sites
by: Kumar, Ammu Prasanna, et al.
Published: (2020) -
Pregnane X receptor (PXR)-mediated gene repression and cross-talk of PXR with other nuclear receptors via coactivator interactions
by: Petr Pavek
Published: (2016-11-01)